SELECT Trial : This major cardiovascular outcomes trial is studying semaglutides impact on heart health in people with obesity but without diabetes
The rate of osteoporosis, a disease where the bones become fragile and brittle, was 3.2% in the group not taking the drug, compared to 4.1% in the GLP-1-taking group
V., Mestrez, F., Sturis, J
Tirzepatide helps by: Improving insulin sensitivity and glucose control Reducing cravings and promoting satiety Supporting smoother, more stable weight loss over time Because of its advanced mechanism, tirzepatide may be especially beneficial for patients who have not achieved their desired results with other weight loss medications
States With Limited Type 2 Diabetes GLP-1 Coverage: A smaller subset of the states mentioned above with no coverage for obesity-indicated GLP-1sincluding the District of Columbia, Florida, and New Jerseyalso limits coverage for Type 2 diabetes-indicated GLP-1s
May Boost Metabolism It can help boost your metabolism, which means youll burn more calories at rest and during exercise